礼来公司 (LLY) 一季度业绩大幅超出预期并上调全年指引

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.3% in the morning session after the stock continued to rally as the company reported strong first-quarter 2026 financial results that surpassed analyst expectations and raised its full-year guidance. The pharmaceutical giant announced that its first-quarter revenue grew 56% to $19.8 billion, significantly beating analyst forecasts.

该内容为新闻快讯，正文已简化。